HSBC Remains a Hold on Wipro Limited (WIPRO)
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
According to TipRanks, Aggarwal is a 4-star analyst with an average return of 10.5% and an 81.25% success rate. Aggarwal covers the Technology sector, focusing on stocks such as LTIMindtree Limited, Cyient Limited, and KPIT Technologies Limited.
In addition to HSBC, Wipro Limited also received a Hold from Morgan Stanley's Gaurav Rateria in a report issued on July 18. However, yesterday, TR | OpenAI – 4o reiterated a Buy rating on Wipro Limited (NSE: WIPRO).
Based on Wipro Limited's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of INR225.04 billion and a net profit of INR35.7 billion. In comparison, last year the company earned a revenue of INR222.08 billion and had a net profit of INR28.35 billion
Based on the recent corporate insider activity of 375 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of WIPRO in relation to earlier this year.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
2 hours ago
- Business Insider
Hims & Hers Health (HIMS) Is About to Report Q2 Earnings. Here's What to Expect
Hims & Hers Health (HIMS) is scheduled to announce its results for the second quarter of 2025 after the market closes on Monday, August 4. HIMS stock has rallied 171% year-to-date, as investors are confident about the prospects of the health and wellness company, including its continued international expansion. However, Wall Street is cautious on Hims & Hers Health stock due to certain concerns, including the recent fallout with Novo Nordisk (NVO) over the alleged illegal sale of compounded versions of the weight loss drug Wegovy. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Wall Street expects HIMS to report earnings per share (EPS) of $0.15, reflecting a 150% year-over-year growth. Sales are expected to grow by about 75% to $551.67 million. TD Cowen Analyst's Views Ahead of Hims & Hers Health's Q2 Earnings Heading into Q2 results, TD Cowen analyst Jonna Kim reiterated a Hold rating on HIMS stock but raised the price target to $43 from $38. The 4-star analyst expects the company to deliver an EPS beat. Kim expects Q2 sales growth to come above the Street's estimate. However, Kim noted that the latest data points indicate a deceleration in trends, which could lead to management maintaining the full-year outlook. The analyst remains neutral on HIMS stock as comparisons get tougher in the second half of 2025, with uncertainty around compounded GLP-1s. Nonetheless, Kim believes that international growth could be meaningful to HIMS' sales starting in Fiscal 2026. Kim noted the rally in HIMS stock and stated that he sees a lack of substantial upside in the second half of 2025, as the company 'laps outsized growth' from last year. AI Analyst Is Bullish on HIMS Stock Ahead of Q2 Print Interestingly, TipRanks' AI stock analyst has assigned an Outperform rating to HIMS stock with a price target of $73, indicating 16.7% downside risk. Based on TipRanks' AI analysis, HIMS stock reflects significant strength in financial performance and strategic growth plans, supported by favorable earnings call insights. However, high valuation and technical indicators suggest caution, especially given potential overbought conditions and margin pressures. Options Traders Anticipate Major Move on Hims & Hers Health's Q2 Earnings Using TipRanks' Options tool, we can see what options traders are expecting from the stock immediately after its earnings report. The expected earnings move is determined by calculating the at-the-money straddle of the options closest to expiration after the earnings announcement. If this sounds complicated, don't worry, the Options tool does this for you. Indeed, it currently says that options traders are expecting about a 17.3% move in either direction in HIMS stock in reaction to Q2 results. Is HIMS Stock a Good Buy? Currently, Wall Street has a Hold consensus rating on Hims & Hers Health stock based on one Buy, seven Holds, and two Sell recommendations. The average HIMS stock price target of $42.33 indicates 32.3% downside risk from current levels.
Business Insider
3 hours ago
- Business Insider
Ford Stock (NYSE:F) Slides on New Sales Numbers
It is a dark day when shareholders in legacy automaker Ford (F) respond to word of improved sales with a sell-off of their own. Because even as Ford managed to bring in some substantial new sales for July, that was not enough to properly fire up shareholders. In fact, shares were down nearly 3% in Friday afternoon's trading. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The sales numbers were terrific. There really is no other way to put it. Ford sales were up around 9% higher than in July 2024, thanks mainly to the still-high popularity of gas-powered trucks and sport utility vehicles (SUVs). And the impressive July numbers added nicely to the solid numbers that have been seen throughout 2025 so far, up about 7% total. The first half of 2024 saw around 1.2 million trucks sold, while 2025's first half gave us over 1.3 million. Trucks represented about 60% of the numbers, while SUVs kicked in the remaining 40%. The biggest reason, according to Ford rep Said Deep, is that the combination of tariff panic buying and employee pricing discounts provided just the right environment for people to buy, and buy Ford. This is indeed good news, but it is also enough to make one wonder what Ford will do for an encore when the third and fourth quarters hit. We've Had This Model T Moment Before So remember yesterday, when we heard about the ' Model T Moment ' that Ford has in mind for August 11? It turns out, reports note, that this is not the first time that CEO Jim Farley has used that phrase. In fact, Ford had a 'Model T Moment' just three years ago, in 2022, when the Ford F-150 Lightning emerged. And that particular moment left some disappointed. Certainly, the electric pickup proved a welcome addition to the lineup, and a frequent buy. But it certainly was nowhere near the iconic status of the car that brought cars to everyday life. And considering that reports have already emerged to say that the newest 'Model T Moment' will be built around an electric car, some are already preparing for disappointment. Is Ford Stock a Good Buy Right Now? Turning to Wall Street, analysts have a Hold consensus rating on F stock based on two Buys, 11 Holds and three Sells assigned in the past three months, as indicated by the graphic below. After a 10.37% rally in its share price over the past year, the average F price target of $10.18 per share implies 5.61% downside risk.
Business Insider
4 hours ago
- Business Insider
Intel Stock (NASDAQ:INTC) Slides as Unanticipated Job Losses Hit
We know that chip stock Intel (INTC) has been hemorrhaging employees for the last several months now, on its way to cutting loose somewhere around 20% of its overall staff. But along the way, Intel is also losing some folks it may not have originally planned to lose. These unexpected departures are hitting Intel particularly hard, and investors do not like what they see. Intel shares were down nearly 2.5% in Friday afternoon's trading. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. With new CEO Lip-Bu Tan making a wide range of changes, some of Intel's biggest names have decided to simply retire and get out of the way altogether. Ryan Russell and Kaizad Mistry, both vice presidents in the technology development group, have decided to retire. Corporate vice president of the Design Technology Platform organization Gary Patton also decided the time was ripe to seek greener pastures in retirement, noted a Reuters report. Intel, interestingly, would not comment about the retirements when asked in that same report. But with processes emerging and being broken apart in a matter of weeks, it is clear there is a lot of change going on at Intel right now. That may be the kind of change that prompts some to believe it is better to abandon ship than go down with it. It Got Worse As if those retirements were not enough, there was one more unexpected departure to follow. This one did not happen as a result of a retirement, though. Rather, this one came about because someone was offered a better job elsewhere. Gang Duan, Inventor of the Year for 2024 at Intel, and a specialist in chip packaging, is now executive vice president at Samsung. (SSNLF) Interestingly, one of the things Duan was known for was using glass as a means to package semiconductors, which provides several key advantages including greater durability and thermal stability. But given that Intel recently decided to get out of glass substrates altogether, Duan may have decided that it was a good time to depart. Is Intel a Buy, Hold or Sell? Turning to Wall Street, analysts have a Hold consensus rating on INTC stock based on one Buy, 25 Holds and three Sells assigned in the past three months, as indicated by the graphic below. After a 7.82% loss in its share price over the past year, the average INTC price target of $22.25 per share implies 15.4% upside potential.
